QUOTE AND NEWS
MedPage Today  10 hrs ago  Comment 
(MedPage Today) -- Cook Medical's Zilver PTX drug-eluting stent for peripheral artery disease has been recalled because of a defect in its associated delivery system, the company and the FDA said.
Benzinga  Mar 19  Comment 
Canaccord Genuity maintained Pernix Therapeutics (NYSE: PTX) with a Buy rating and lowered the price target from $14.00 to $12.00. Canaccord Genuity analyst Randall Stanicky commented, "The lower 2013 outlook will temper forecasts and was...
Benzinga  Mar 19  Comment 
Cantor Fitzgerald downgraded Pernix Therapeutics Holdings (NYSE: PTX) from Buy to Hold and lowered the price target to $7.00. Cantor Fitzgerald analyst Irina Rivkind commented, "The company reported larger-than-expected declines in its...
StreetInsider.com  Mar 18  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Pfizer+%28PFE%29%2C+Protalix+%28PTX%29+UPLYSO+Receives+Approval+in+Brazil/8192828.html for the full story.
StreetInsider.com  Mar 18  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Pernix+Therapeutics+Holdings+%28PTX%29+Posts+Surprise+Q4+Loss+of+5cShare/8191405.html for the full story.
StreetInsider.com  Jan 24  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Pernix+Therapeutics+%28PTX%29+to+Restructure+Sales+Force%2C+CFO+Resigns/8028439.html for the full story.
StreetInsider.com  Jan 15  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Equity+Offerings/Pernix+Therapeutics+%28PTX%29+to+Offer+5.1M+Shares+for+Holders/8010596.html for the full story.
Benzinga  Dec 12  Comment 
In a report published Wednesday, Cantor Fitzgerald reiterated its Buy rating on Pernix Therapeutics Holdings (NYSE: PTX), but lowered its price target from $17.00 to $15.00. Cantor Fitzgerald noted, “While the stock remains fundamentally...
StreetInsider.com  Dec 11  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Pernix+%28PTX%29+to+Acquire+Somaxon+%28SOMX%29+in+%2425M+All-Stock+Deal/7938055.html for the full story.
Forbes  Nov 15  Comment 
The FDA today approved Cook Medical's Zilver PTX stent. It is the first drug-eluting stent (DES) approved for the treatment of peripheral arterial disease (PAD) in the superficial femoral and proximal (i.e., above the knee) popliteal artery. The...





 



References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki